LAMEA Endometriosis Market Size, Share & Industry Trends Analysis Report By Type, By Treatment (Oral Contraceptives, Gonadotropin-releasing hormone (GnRH) medicines, and Others), By Distribution Channel, By Country and Growth Forecast, 2022 - 2028
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the LAMEA Endometriosis Market
Market Report Description
The Latin America, Middle East and Africa Endometriosis Market would witness market growth of 14.0% CAGR during the forecast period (2022-2028).
A laparoscopy may be advised in specific circumstances in order to examine and surgically remove or destroy troublesome tissue. Both symptoms and fertility can be improved by doing this. Laparoscopic excision or ablation can be done by doctors. Excision involves cutting troublesome tissue away, whereas ablation involves burning the tissue with a laser or cauterizer.
In most cases dof mild or severe endometriosis, surgery relieves symptoms, although it is not always successful, and recurrence (and the requirement for additional surgical procedures) are frequent over time. Additionally, there are dangers associated with surgery that must be evaluated against any potential advantages.
In difficult situations, once all other options for therapy have been explored, a hysterectomy (removal of the fallopian tubes, uterus, and occasionally the ovaries) may be considered. Even while a hysterectomy does not always successfully treat endometriosis, it does have lower retreatment rates than other procedures, particularly when the ovaries are also removed.
The Saudi Arabian government has budgeted about $65 billion for the development of the healthcare system as part of Vision 2030. Additionally, it wants to privatize 290 hospitals and 2,300 primary health centers by 2030, increasing private sector participation from 40% to 65%. The MOH intends to establish health clusters across Saudi Arabia in order to encourage preventive and integrated care and to increase access to health service. One million individuals will be served by each cluster's integrated network of healthcare professionals. A strong healthcare industry and increasing government spending, particularly on women's health care, will serve as an opportunity for the market players in the endometriosis market.
The Brazil market dominated the LAMEA Endometriosis Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $35.7 million by 2028. The Argentina market is exhibiting a CAGR of 14.6% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 13.6% during (2022 - 2028).
Based on Type, the market is segmented into Superficial Peritoneal Lesion, Endometriomas, and Others. Based on Treatment, the market is segmented into Oral Contraceptives, Gonadotropin-releasing hormone (GnRH) medicines, and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide Endometriosis Market is Projected to reach USD 2.2 Billion by 2028, at a CAGR of 11.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Sanofi S.A., AbbVie, Inc., AstraZeneca PLC, Pfizer, Inc., Merck & Co., Inc., GlaxoSmithKline PLC, Abbott Laboratories, and Consilient Health Limited.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Superficial Peritoneal Lesion
- Endometriomas
- Others
By Treatment
- Oral Contraceptives
- Gonadotropin-releasing hormone (GnRH) medicines
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Teva Pharmaceuticals Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Sanofi S.A.
- AbbVie, Inc.
- AstraZeneca PLC
- Pfizer, Inc.
- Merck & Co., Inc.
- GlaxoSmithKline PLC
- Abbott Laboratories
- Consilient Health Limited
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Related Reports:
Global Endometriosis Market Report 2022-2028
North America Endometriosis Market Report 2022-2028